
AUTOLOGOUS EXOSOMES
Exosomes in men's sexual health — what the research shows so far.
Exosomes in men's sexual health — what the research shows so far.
Why exosomes are studied in erectile dysfunction
Erectile dysfunction is one of the most common conditions in men over 40, and in many men it has a vascular cause. Platelet-derived exosomes carry growth factors such as VEGF, PDGF-BB and bFGF, which are linked to new blood-vessel formation and tissue repair in laboratory studies. This regenerative signalling is the scientific rationale for research in men's sexual health.

An early research field
Pre-clinical Studies
A 2023 systematic review and meta-analysis in Sexual Medicine found that stem cell–derived exosomes improved erectile function in rat models.
PRP in Men
A randomised placebo-controlled trial of 50 men with vasculogenic ED (Arab Journal of Urology) reported a significant difference from placebo in the mild-ED subgroup at 3 and 24 months.
PRP-derived Exosomes
A feasibility trial in Greece (NCT07124871) began recruiting in 2025 to test PRP-derived exosome injections in 30 men; results are not yet published.
Exosome therapy for erectile dysfunction is still at an early clinical stage. There is not yet a published clinical study of MyExo in erectile dysfunction, and MyExo is not presented as a proven ED treatment. Any use is a decision for a qualified urologist or andrologist after a full assessment, in line with local regulations.
Sex Med. 2023;11(2):qfac019. doi:10.1093/sexmed/qfac019 · Feng H, et al. Front Endocrinol. 2023;14:1123383 · Arab J Urol. 2025;23(2):160–166. doi:10.1080/20905998.2024.2424459 · ClinicalTrials.gov NCT07124871
Talk to our team about MyExo.
For healthcare professionals. Product information provided by the manufacturer. Distributed by Bionics Medical in the UAE and Saudi Arabia.